Congress Bars EPA from accepting human pesticide data

Congress Bars EPA from accepting human pesticide data Thu, 28 Jul 2005 Thank you Senator Barbara Boxer and Representative Hilda Solis for leading the charge to stop the Environmental Protection Agency in its tracks. The EPA was formulating rules that would have oveturened the Nuremberg Code prohibition against using poisonous…

| | | |

AIDS Drug Experiments on Foster Care Children – A National Scandal

Wed, 04 May 2005 Researchers Tested AIDS Drugs on Children, Associated Press On March 10, 2004, The Alliance for Human Research Protection filed a complaint with the FDA and the federal Office of Human Research Protection about a series of AIDS drug experiments conducted on New York City children in…

National Institue AIDS Research–Professional Women Describe Sex Harassment – Conduct Unbecoming

National Institue AIDS Research–Professional Women Describe Sex Harassment – Conduct Unbecoming Mon, 11 Apr 2005 Just when the NIH announced that it was in the clear – citing a report issued (April 6) by a panel of the Institute of Medicine "exonerating" NIH and rejecting the allegations by Dr. Jonathan…

At FDA, Graham is still the whistle-blower – USA Today

At FDA, Graham is still the whistle-blower – USA Today Thu, 17 Nov 2005 On Nov. 18, 2004, Dr. David Graham, FDA’s associate director for science and medicine, blew the whistle in testimony before the Senate Finance Committee, on FDA’s “profound regulatory failure” to protect the public against lethal prescription…

FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing

Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.

Industry Influence: FDA “Critical Path”/ Biased Research: BMJ / NIH: still smoke & mirrors

The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.